Cover Image
市場調查報告書

內臟器官·組織移植的全球市場

Organ and Tissue Transplantation

出版商 Global Industry Analysts, Inc. 商品編碼 236773
出版日期 內容資訊 英文 275 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
內臟器官·組織移植的全球市場 Organ and Tissue Transplantation
出版日期: 2018年03月01日 內容資訊: 英文 275 Pages
簡介

本報告提供全球內臟器官·組織移植市場相關調查分析,提供全球器官移植(心臟,腎臟,肝臟,肺,角膜移植)等各產品區隔考察,以及美國市場各內臟器官(心臟,腎臟,肝臟,胰臟,肺,腸),組織(角膜,心臟瓣膜,皮膚,血管,骨髓,骨),骨移植(自我移植,同類移植,其他)之用途別考察,美國,加拿大,日本,歐洲,亞太地區,南美,全球其他各國等市場別相關分析,再彙整今後的市場預測,過去6年的市場分析,主要企業簡介等相關資訊。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 市場概要
    • 市場預測
    • 現在與未來的分析
    • 內臟器官捐贈者概要
    • 最多的器官移植腎臟·肝臟移植
    • 供需的不平衡
    • 解決內臟器官不足的問題
    • 心臟麻痺死患者:潛在的捐贈者
    • 循環死亡後捐贈:充斥著倫理問題
    • 移植:支出和不同地區差異
    • 骨移植概要
    • 其他移植
  • 市場趨勢
  • 移植影響市場的主要因素
  • 產品概要
    • 器官移植
    • 心臟移植
    • 腎臟移植
    • 肝臟移植
    • 胰臟移植
    • 小腸移植
    • 肺移植
    • 心臟/肺移植
    • 組織移植
    • 移植的種類
    • 角膜移植
    • 血液幹細胞
    • 骨/組織移植
    • 骨髓移植
    • 心臟瓣膜
    • 胎兒細胞
    • 保存期限
    • 冷缺血時間
    • 移植免疫學
    • 急性細胞性排斥反應
    • 慢性排斥反應
    • 移植後觀察
    • 捐贈者的種類
    • 內臟器官/組織的提供和申請資格標準
    • 提供內臟器官和接收者的選配
    • 檢驗
    • 血型
    • 組織型
    • 組織適合性
    • 移植的安全必要條件
    • 等待候補名單
    • 歷史
    • 器官移植主要的里程碑
  • 人造器官:固態器官移植的替代品
  • 保存的解決方案,免疫抑制劑
  • 法規環境
  • 近來產業活動
  • 全球主要企業
  • 全球市場概要

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 全球其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1572

This report analyzes the worldwide markets for Organ and Tissue Transplantation in Volume Terms (Number of Procedures). The Global and Regional markets (except the US) are analyzed by the following Product Segments: Heart, Kidney, Liver, Pancreas, and Lung, and Corneal Transplantation. The US market is analyzed by the following Segments: Organ Type (In Volume and Value) - Heart, Kidney, Liver, Pancreas, Lung, and Intestine; Tissue Type (Volume Only) - Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts; and Bone Graft Transplantation (Volume Only) -By Graft Type: Autologous Graft, Allograft, and Other Materials; and By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 19 companies including many key and niche players such as -

Acelity L.P. Inc.
CryoLife, Inc.
Exactech, Inc
Dr. Franz Kohler Chemie GmbH
Organogenesis, Inc.
Organ Recovery Systems

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Organ Transplantation
    • Heart Transplantation
    • Kidney Transplantation
    • Liver Transplantation
    • Pancreas Transplantation
    • Small Intestine Transplantation
    • Lungs
  • Tissue Transplantation
    • Corneal Transplantation
    • Blood Stem Cell Transplantation
    • Bone Marrow Transplantation
    • Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Market Outlook
  • Current & Future Analysis
  • A Review of Organ Donors Worldwide
    • Table 1: World Deceased Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart)
    • Table 2: World Living Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart)
    • Table 3: World Deceased Organ Donors by Type (2011, 2013 & 2015): Percentage Breakdown of Number of Donors for DCD and DBD (includes corresponding Graph/Chart)
  • Demand and Supply Imbalance
  • Measures to Address Organ Shortage...
  • Cardiac Arrest Death Patients: The Untapped Potential Donors
    • Table 4: World Organ Donors After Circulatory Death (2016): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart)
  • Donation after Circulatory Death - Rife with Ethical Issues
  • Transplantation - Expenditure and Regional Variations
    • Table 5: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart)
  • Bone Grafts: An Overview
    • Table 6: Fractures by Age Group (2017E): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart)
  • Orthopedic Grafts - Regional Market Variations

2. MARKET TRENDS

  • Combined Organ Transplantation - Gaining Attention
  • Illegal Organ Trafficking - A Risky Proposition
  • Transplant Tourism - Creating Brighter Avenues
  • Graying Population and Chronic Diseases Surge Need for Transplants
    • Table 7: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 8: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 9: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart)
    • Table 10: Global Life Expectancy at Birth (Years) by Geographic Region: 1950-2050 (includes corresponding Graph/Chart)
    • Table 11: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart)
  • Optimization Strategies for Organs Catch Attention and Supply-Demand Gap Widens
  • Advent of Innovative Devices Mitigate Chances of Organ Damages
  • Investment Opportunities Rise for Allied Fields as Organ Transplantation Market Grows
  • Shortage of Organs Propels Research on Xenotransplantation
  • A Peek into the Organ Transplant Immunosuppressants Market
  • Market to Come Under Tremendous Pressure
  • Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation
    • Table 12: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
  • Fetal Tissue for Bionic Devices - Assuming Importance
  • LVADs - Gaining Significance for Impending Heart Transplants
  • Synthetic Bone Graft - The Latest Trend
  • Stem Cell Therapies - Expanding the Horizon of Transplantation
  • Rising Cancer Incidence to Drive Stem Cell Transplants
    • Table 13: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 14: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
  • Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition
  • Bone Morphogenetic Protein - Safety Concerns Affect Growth Prospects
  • Dental Bone Grafting - A High Potential Market
    • Table 15: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart)
  • Key Recent Technological Innovations
  • 3-D Bioprinting
  • Preloaded Corneal Tissue Cartridges
  • Lung Perfusion Technology

3. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET

  • Organ Rejection - A Major Barrier to Transplantation
  • Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
  • Other Issues for Organ Transplantation
  • Ethical Concerns in Transplants
  • Bioethical Issues Hinder Organ Donation Process
  • Lack of Requisite Expertise - Hindering Implantation Process
  • Corneal Transplantation in Developing Countries: Key Challenges

4. PRODUCT OVERVIEW

  • Organ Transplantation
  • Heart Transplantation
    • Heart Diseases and Disorders
    • Post-Operative Complications and Consequences of Heart Transplants
      • Bleeding
      • Infection
      • Arrhythmia
      • Heart Attack
      • Coronary Artery Disease
      • Respiratory Dysfunction
      • Renal Dysfunction
      • Graft Rejection and Dysfunction
      • Death
  • Kidney Transplantation
    • Kidney Disorders and Diseases
    • Donor Evaluation
    • Waiting List
    • Surgery/Post-Operation
    • Post-Operative Supervision and Issues
  • Liver Transplantation
    • Liver Disorders and Diseases
  • Pancreas Transplantation
    • Post-Operative Complications and Consequences of Pancreas Transplants
  • Small Intestine Transplantation
    • Intestine Disorders and Diseases
  • Lung Transplantation
    • Lung Diseases and Disorders
    • Lung Patients Survival Statistics
  • Heart-and-Lung Transplantation
  • Tissue Transplantation
  • Types of Grafts
    • Autograft
    • Allograft/Homograft
      • Transplant Tolerance
    • Isograft
    • Xenograft
  • Corneal Transplantation
    • Penetrating Keratoplasty
    • Lamellar (Non-Penetrating) Keratoplasty
    • Aftercare
    • Risks Associated with Corneal Transplants
    • Transplantation Outcomes
    • Morbidity and Mortality Rates
    • Alternatives
  • Blood Stem Cells
    • Peripheral Blood Stem Cell Transplant
    • Umbilical Cord Blood Stem Cell Transplant
    • Bone Marrow and Hematopoietic Stem Cells
  • Bone and Tissue Transplantation
  • Bone Marrow Transplants
    • Stem Cell Therapy
  • Human Heart Valves
    • Atrioventricular Valves
      • Mitral Valve
      • Tricuspid Valve
    • Semilunar Valves
      • Aortic Valve
      • Pulmonic Valve
    • Pathology of Valves
    • Prosthetic Heart Valves
    • Prosthetic Mechanical Valve
      • Advantages
      • Disadvantages
    • Prosthetic Biologic Valve
      • Advantages
      • Disadvantages
  • Fetal Cells
    • Fetal Tissue for Transplantation
  • Storage Duration Time
    • Storage Time Period for Organs and Tissues
  • Cold Ischemia Time
  • Transplantation Immunology
  • Acute Cellular Rejection
  • Chronic Rejection
  • Post-Transplant Observations
  • Types of Donors
  • Alive Donors
  • Related Donors
  • Good Samaritans
  • Rewarded/Forced Donors
  • Deceased Donors
  • Directed / Allocated
    • Organs and Tissues Transplanted by Type of Donor
  • Organ/Tissue Donation and Eligibility Criteria
  • Factors Considered for Matching Recipients to Donor Organs
  • Testing
  • Blood Typing
  • Tissue Typing
  • Histocompatibility - A Major Barrier for Organ Transplantation
  • Transplantation - Safety Requirements
  • Waiting List
  • Active Waiting List Patients
  • Inactive Waiting List Patients
  • History
  • Major Milestones in Organ Transplantation

5. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS

  • Artificial Organs Revolutionize Medical Technology Industry
  • Artificial Organs
  • Categorization of Artificial Organs
    • External Artificial Organs
    • Internal or Implantable Artificial Devices
  • Artificial Heart
    • Total Artificial Heart (TAH)
    • Ventricle Assist Device (VAD)
      • Right Ventricular Assist Systems (RVAS)
      • Left Ventricular Assist Systems (LVAS)
      • Select Ventricular Assist Devices
  • Artificial Kidney (Dialyzer)
    • Limitations of Artificial Kidney
  • Artificial Liver
    • Select Liver Assist Devices
    • Categorization of Liver Devices
      • Mechanical Systems
      • Bio-Artificial Systems
  • Artificial Pancreas
  • Artificial Lungs (Oxygenator)
    • Types of Artificial Lung
  • Artificial Cornea
    • Keratoprostheses
      • Tissue Engineered Corneas
  • Artificial Skin/Skin Replacement Products
    • AlloDerm Regenerative Tissue Matrix
    • Apligraf
    • Cymetra Micronized AlloDerm Tissue
    • Dermagraft
    • Epicel
    • Integra Products
    • OrCel
    • TransCyte
  • Core Competitive Factors
  • Market Outlook for Artificial Organs

6. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS

  • Organ Preservation Solutions
  • Celsior Solution
  • Collins Solution
  • Euro Collins Solution
  • Custodiol(r) HTK Solution
  • Hypothermosol
  • ViaSpan
  • Immunosuppressant Drugs
  • Antibody Products for Treatment of Organ Transplant Rejection
    • Antithymocyte Globulin
    • ATGAM
    • Thymoglobulin
  • Therapeutic Antibody Products
    • Antiproliferative Agents
    • Azathioprine
    • CellCept
    • Certican
    • Myfortic
    • Calcineurin Inhibitors
      • Cyclosporine
      • Gengraf
      • Neoral
      • Prograf (Tacrolimus)
    • TOR Inhibitors
  • Side Effects of Immunosuppression Therapy

7. REGULATORY ENVIRONMENT

  • Transplant Center
  • Organ Procurement Organization (OPO)
  • Health Resources and Services Administration (HRSA)
  • Division of Transplantation (DoT)
  • United Network for Organ Sharing (UNOS)
  • Organ Procurement and Transplantation Network (OPTN)
  • University Renal Research and Education Association (URREA)
  • Scientific Registry of Transplant Recipients (SRTR)
  • Funding Sources
  • Patient Education and Advocacy Organizations
  • Legal Framework for Transplantation
  • Legislation Covering Organ Transplant
  • Organ Transplantation and Ethics

8. PRODUCT LAUNCHES

  • Royal Biologics Launches Demineralized Bone Matrix Product, MAXX-Fuse
  • Extremity Medical Launches Next-Gen Viable Cell Bone Graft, BioFuse
  • AlloSource Launches Two New Demineralized Cortical Fiber Allografts
  • Immucor Launches Kidney Solid Organ Response Test, kSORT

9. RECENT INDUSTRY ACTIVITY

  • Exactech Merges with TPG Capital
  • CryoLife Acquires JOTEC
  • SeaSpine Receives FDA Approval for OsteoBallast(tm) DBM in Resorbable Mesh
  • Medtronic Receives FDA Approval for Endurant(tm) II/IIs Stent Graft System
  • Organogenesis Acquires NuTech Medical
  • Allergan to Acquire Acelity's LifeCell Business Unit
  • CryoLife Acquires On-X Life Technologies
  • MiMedx Group Acquires Stability Biologics

10. FOCUS ON SELECT PLAYERS IN ALLIED AREAS

  • Acelity L.P. Inc. (USA)
  • CryoLife, Inc. (USA)
  • Exactech, Inc. (USA)
  • Dr. Franz Kohler Chemie GmbH (Germany)
  • Organogenesis, Inc. (USA)
  • Organ Recovery Systems (USA)
  • Organ Transport Systems (USA)
  • XVIVO Perfusion AB (Sweden)

11. GLOBAL MARKET PERSPECTIVE

    • Table 16: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 18: World 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 21: World 14-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 24: World 14-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 25: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 27: World 14-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 30: World 14-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 33: World 14-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 36: World 14-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Organ Transplant Sector Holds Growth Potential
    • Table 37: Number of Transplants and Waiting List for Organ Transplantation in the US: 2005 & 2016 (In Thousands) (includes corresponding Graph/Chart)
    • Table 38: Organ Transplantation Donors in the US by Type (2016): Number of Organ Donors in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart)
    • Table 39: Organs Donated for Transplantation in the US by Type (2016): Number of Donated Organs in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart)
    • Table 40: US Deceased Donors by Ethnicity (2016): Percentage Breakdown of Number of Donors for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart)
    • Table 41: Transplant Recipients in the US by Ethnicity (2016): Percentage Breakdown of Number of Transplants for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart)
    • Waiting List for Organ Transplants in the US
    • Table 42: Organ Transplant Waiting List in the US by Ethnicity (2017): Percentage Breakdown of Number of People on Waiting List for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart)
    • Select Market Trends
      • Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants
      • Innovative Education Programs Contribute to Higher Organ Donors
      • Awareness Programs to Address Shortage of Minority Donors
      • US Organ Procurement Organizations by State
      • KPD Enables Compatibility Factor for Kidney Transplants
      • Tissue Transplantation in the US
    • Dental Bone Graft Substitutes Market: An Overview
      • Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market
    • Rising Incidence of Degenerative Intervertebral Disc Diseases - Opportunity Indicators for Bone Grafts
      • Osteoporosis
    • Table 43: Osteoporosis and Low Bone Mass Population in the US: 2010 & 2020 (includes corresponding Graph/Chart)
    • Table 44: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
    • Regulatory Bodies
      • The United Network for Organ Sharing
      • The American Association of Tissue Banks (AATB)
      • Accredited Banks from Select US States
      • Eye Banks from Select US States
      • National Organ Transplant Act (NOTA)
      • Good Tissue Practices
      • Tissue Banking Regulation
      • FDA Regulations on Xenograft
      • DBM-based Products in US
      • Synthetic Bone Graft Substitutes
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • By Value Sales
    • Table 45: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 46: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 47: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 48: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 49: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • By Number of Procedures
    • Table 50: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 52: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 53: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 54: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 55: The US 14-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 56: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 57: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 58: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 59: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 60: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 61: The US 14-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Canadians More Receptive to Organ Transplants
    • Table 62: Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Manitoba, Ontario, Quebec, Saskatchewan and Others (includes corresponding Graph/Chart)
    • Table 63: Combination Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Ontario and Quebec (includes corresponding Graph/Chart)
    • Table 64: Combination Organ Transplants in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Kidney-Liver, Kidney-Pancreas, Liver-Small Intestine, Multi-visceral Cluster and Others (includes corresponding Graph/Chart)
    • Organ Donors
    • Table 65: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2012-2016 (includes corresponding Graph/Chart)
    • Table 66: Living Donor Transplants in Canada by Organ (2016): Percentage Breakdown of Number of Transplants for Kidney, Kidney Paired Donation, and Liver (includes corresponding Graph/Chart)
    • Table 67: Deceased Organ Donations in Canada (2016): Organ Donations Per Million Population (PMP) by Province (includes corresponding Graph/Chart)
    • Waiting List
    • Table 68: Organ Transplantation Waiting List in Canada (2016): Number of Patients on Waiting List by Organ Type - Heart, Kidney, Liver, Lung, Pancreas and Others (includes corresponding Graph/Chart)
    • Table 69: Waiting List Trends in Recent Past (2012-2016): Number of Patients on Waiting List for Heart, Kidney, Liver and Lung Transplantation (includes corresponding Graph/Chart)
    • Table 70: Combination Organ Transplants Waiting List in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Heart-Liver, Kidney-Heart, Kidney-Pancreas, Kidney-Liver, Liver-Lung, Liver-Small Intestine and Others (includes corresponding Graph/Chart)
    • Favorable Growth Prospects in Bone Graft Substitutes Market
  • B. Market Analytics
    • Table 71: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 72: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 73: Canadian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Terumo Corporation (Japan) - A Key Player
  • B. Market Analytics
    • Table 74: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 75: Japanese Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 76: Japanese 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Statistics
    • Table 77: European Organ Transplantation Rate in Per Million Population for Leading Countries: 2016 (includes corresponding Graph/Chart)
    • Table 78: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2016 (includes corresponding Graph/Chart)
    • Table 79: European Living Organ Donors Per Million Population (PMP) in Select Leading Countries: 2016 (includes corresponding Graph/Chart)
    • Policy Changes - Key to Bridge Variability in Kidney Donors and Transplants across Europe
  • B. Market Analytics
    • Table 80: European Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 81: European Historic Review for Organ Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 82: European 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 83: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 84: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 85: European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Organ Donation Statistics
    • Table 86: Organ Donations in France (2016): Number of Donors and PMP by Type - Deceased and Living (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 87: French Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 88: French Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 89: French 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 90: German Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 91: German Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 92: German 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
    • Surge in Organ Transplants
    • Table 93: Organ Donations in Italy (2016): Number of Donors and PMP by Type - Deceased and Living (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 94: Italian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 95: Italian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 96: Italian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Organ Transplantation in the UK
    • Key Statistics
    • Table 97: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2012-13 through 2016-17 (includes corresponding Graph/Chart)
    • Table 98: Deceased Organ Donors in the UK by Organ and Country (2017): Number of Organ Donors for England, Scotland, Wales and Northern Ireland (includes corresponding Graph/Chart)
    • Table 99: Organ Transplantation Waiting List in the UK by Organ and Country (2017): Number of People on Waiting List for England, Scotland, Wales and Northern Ireland (includes corresponding Graph/Chart)
    • Table 100: Deceased Solid Organ Donors in the UK by Organ Type and Type of Death: 2016-17 (includes corresponding Graph/Chart)
    • Table 101: Organs Retrieved per Deceased Donor by Country (2016-17): Average Number of Organs Retrieved from Deceased Patients of all Ages for England, Wales, Scotland and Northern Ireland (includes corresponding Graph/Chart)
    • Table 102: Organ Donors in the UK by Age Group and Death Type: 2016-17 (includes corresponding Graph/Chart)
    • The UK Organ Transplantation System: An Overview
  • B. Market Analytics
    • Table 103: UK Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 104: UK Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 105: UK 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Spain - A Global Leader in Organ Donation
  • B. Market Analytics
    • Table 106: Spanish Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 107: Spanish Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 108: Spanish 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current & Future Analysis
    • Organ Transplantations Show a Downward Trend in Russia
    • Organ Donation Statistics
    • Table 109: Organ Donations in Russia (2016): Number of Donors and PMP by Type - Deceased and Living (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 110: Russian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 111: Russian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 112: Russian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Turkey
    • Table 113: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart)
    • Table 114: Organ Donations in Turkey (2016): Number of Donors by Type - Deceased and Living (includes corresponding Graph/Chart)
    • Akdeniz University - A World-Renowned Transplantation Center
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 115: Rest of European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 116: Rest of European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 117: Rest of European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Table 118: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2016 (includes corresponding Graph/Chart)
    • Table 119: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2012, 2014 & 2016 (includes corresponding Graph/Chart)
    • Thriving Orthopedic Biomaterials Market in Asia-Pacific
    • Focus on Select Regions
      • Australia - One of the Major Organ Transplant Markets in Asia-Pacific
      • Key Facts on Organ and Tissue Transplantation in Australia
      • Organ Transplantations Reach Record Highs
    • Table 120: Organ Donations in Australia (2016 & 2017): Number of Organ Donors by Type - Deceased (DBD and DCD) and Living (AKX and Others) (includes corresponding Graph/Chart)
    • Table 121: Organs and Tissue Donor Volume in Australia by Type: 2017 (includes corresponding Graph/Chart)
    • Table 122: Deceased Organ Donors and Donor PMP in Australia by State: 2017 (includes corresponding Graph/Chart)
    • Table 123: Organ Transplantations Volume in Australia by Organ: 2016 & 2017 (includes corresponding Graph/Chart)
    • Table 124: Tissue Donations in Australia (2016 & 2017): Number of Deceased Tissue Donations by Type - Musculoskeletal, Cardiovascular and Skin (includes corresponding Graph/Chart)
      • Government Efforts Key for Improving Organ Donation Activity
      • Government Mulls Easing Registration Process Further
      • China
      • Chinese Organ Transplant Market - Embroiled in Controversy
      • A New and Promising Legal Organ Transplantation Set Up Emergence in China
      • Transplantation Tourism in China
      • Low Transplant Success Rate Due to Unskilled Professionals
      • Illegal Activities for Harvesting Organs in China
      • Regulations on Organ Transplantation
      • Regulations on Brain Death
      • India
      • Organ Transplantation in India - Present Status
      • Rise in Medical Tourism Drives Bone Grafts Market
      • Aging Population Boosts the Indian Orthopedic Market
      • The Current Status of Organ Donation and Transplantation
      • Overview of Renal Transplantation
      • Structural Deficiencies Affecting Indian Organ Donation Space
      • Singapore
      • Awareness Programs to Increase Living Kidney Donations in Singapore
  • B. Market Analytics
    • Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 126: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 127: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current & Future Analysis
    • Dental Bone Graft Substitutes Market - Overview
    • Key Statistics
    • Table 128: Latin American Deceased and Living Organ Donors Per Million Population (PMP) by Country: 2016 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 129: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 130: Latin American Historic Review for Organ Transplantation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 131: Latin American 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for Brazil and Rest of Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 132: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 133: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 134: Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Current & Future Analysis
    • Brazil - A Major Transplant Market
  • B. Market Analytics
    • Table 135: Brazilian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 136: Brazilian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 137: Brazilian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 138: Rest of Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 139: Rest of Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 140: Rest of Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 141: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 142: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 143: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Back to Top